Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Amati AIM ( (GB:MRV) ) is now available.
Maven Renovar VCT’s board plans to seek shareholder approval in June 2026 to amend its investment policy to an “AIM Plus” strategy, enabling greater investment in unquoted companies alongside its existing AIM and Aquis portfolio. The move follows a strategic review and a shareholder survey in which a majority of respondents backed the shift, although some asked for further detail before committing support.
To accommodate investors who prefer to exit before any strategy change, the company intends to launch a shareholder tender offer ahead of the 2026 AGM, on terms designed to simplify participation for both certificated and uncertificated holders. The tender will follow the record date of a previously announced special dividend, ensuring all existing investors receive the payout while any shares sold back to the company under the offer will trade ex-dividend.
More about Amati AIM
Maven Renovar VCT PLC is a UK-listed venture capital trust investing primarily in smaller growth companies, with a focus on holdings quoted on London’s AIM and Aquis markets. The board is considering an “AIM Plus” strategy that would expand its mandate to include a higher allocation to unquoted private companies while maintaining compliance with VCT rules.
Average Trading Volume: 29,314
Technical Sentiment Signal: Sell
See more insights into MRV stock on TipRanks’ Stock Analysis page.